AYTU BIOPHARMA, INC short interest in 2025
In 2025, AYTU BIOPHARMA, INC's disclosed short interest ran from 2.14% of shares outstanding on 15 Jan 2025 to 5.04% on 31 Dec 2025, a change of +2.90 percentage points. The year's high was 12.00% on 15 May 2025 and its low 1.86% on 14 Mar 2025, averaging 5.29% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.24 days on 28 Nov 2025. Full history: AYTU BIOPHARMA, INC.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 2.14% (15 Jan 2025)
- End of year
- 5.04% (31 Dec 2025)
- Change
- +2.90 pp
- High
- 12.00% (15 May 2025)
- Low
- 1.86% (14 Mar 2025)
- Average
- 5.29%
- Highest days to cover
- 9.24 (28 Nov 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 2.14% | 5.19 | |
| 31 Jan 2025 | 2.08% | 6.73 | |
| 14 Feb 2025 | 2.01% | 3.88 | 10-Q filed, results (8-K) |
| 28 Feb 2025 | 1.95% | 2.56 | |
| 14 Mar 2025 | 1.86% | 2.93 | |
| 31 Mar 2025 | 1.90% | 3.18 | |
| 15 Apr 2025 | 1.92% | 3.39 | |
| 30 Apr 2025 | 2.20% | 4.70 | |
| 15 May 2025 | 12.00% | 1.00 | 10-Q filed, results (8-K) |
| 30 May 2025 | 6.75% | 1.00 | |
| 13 Jun 2025 | 10.12% | 1.00 | |
| 30 Jun 2025 | 7.98% | 1.95 | |
| 15 Jul 2025 | 8.54% | 3.74 | |
| 31 Jul 2025 | 9.48% | 3.50 | |
| 15 Aug 2025 | 7.63% | 3.86 | |
| 29 Aug 2025 | 7.53% | 5.95 | |
| 15 Sep 2025 | 4.66% | 5.89 | |
| 30 Sep 2025 | 6.10% | 1.20 | 10-K filed, results (8-K) |
| 15 Oct 2025 | 6.18% | 2.33 | |
| 31 Oct 2025 | 5.04% | 6.11 | |
| 14 Nov 2025 | 4.78% | 7.75 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 4.49% | 9.24 | |
| 15 Dec 2025 | 4.54% | 7.99 | |
| 31 Dec 2025 | 5.04% | 3.86 |
See also: AYTU BIOPHARMA, INC's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.